White House: TrumpRx and Most-Favored-Nation Drug Pricing Expand
September 10, 2026 · The White House · 0:02:21
Embedded from the source channel — never re-uploaded. Watch on YouTube
What happened
The White House compilation presents most-favored-nation drug pricing as, in the speakers’ words, about fairness to the American consumer. President Trump is heard saying the United States will no longer subsidize the health care of foreign countries or tolerate profiteering and price gouging, and that Americans pay on average three times more for the same drugs, in the same bottles from the same factories, as buyers in Europe.
Speakers in the video describe cutting out middlemen so drugs can be sold directly to American citizens at the most-favored-nation price, and call the policy a shield for the chronically ill who have carried the burden of high drug costs.
The closing speaker says nine more companies are getting into the program, bringing participation to 14 of the 17 big companies, and that dozens of commonly used prescription drugs will be available at dramatic discounts through TrumpRx.gov. That speaker states the site has been visited more than 10 million times since its February launch and has saved American consumers over $400 million, and cites a Council of Economic Advisers estimate that most-favored-nation policies will save Americans over $500 billion over the next 10 years.
Why it matters
The video is the administration’s progress report on its signature drug-pricing initiative, tying the TrumpRx direct-purchase site and manufacturer agreements to claimed consumer savings.
Scoreboard watch
The video states TrumpRx.gov had over 10 million visits and over $400 million in consumer savings since February, with 14 of 17 major companies participating; those figures are checkable against subsequent White House and CMS reporting.
Sources: The White House, “Promises Made, Promises Kept: TrumpRx”, 2026-09-10 (official upload, embedded above; published 2026-09-10). Transcript via Supadata (private research store, paraphrased and attributed, not republished). All figures and characterizations as stated by the speakers.
On this page